Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

1548. Lopez-Beltran A, Croghan GA,
Croghan I, Matilla A, Gaeta JF (1994).
Prognostic factors in bladder cancer. A
pathologic, immunohistochemical, and
DNA flow-cytometric study. Am J Clin
Pathol 102: 109-114.
1549. Lopez-Beltran A, Escudero AL,
Cavazzana AO, Spagnoli LG, Vicioso-
Recio L (1996). Sarcomatoid transitional
cell carcinoma of the renal pelvis. A
report of five cases with clinical, pathological,
immunohistochemical and DNA
ploidy analysis. Pathol Res Pract 192:
1218-1224.
1550. Lopez-Beltran A, Lopez-Ruiz J,
Vicioso L (1995). Inflammatory pseudotumor
of the urinary bladder. A clinicopathological
analysis of two cases. Urol Int 55:
173-176.
1551. Lopez-Beltran A, Luque RJ,
Mazzucchelli R, Scarpelli M, Montironi R
(2002). Changes produced in the urothelium
by traditional and newer therapeutic
procedures for bladder cancer. J Clin
Pathol 55: 641-647.
1552. Lopez-Beltran A, Luque RJ, Moreno
A, Bollito E, Carmona E, Montironi R (2002).
The pagetoid variant of bladder urothelial
carcinoma in situ. A clinicopathological
study of 11 cases. Virchows Arch 441: 148-
153.
1553. Lopez-Beltran A, Luque RJ, Vicioso
L, Anglada F, Requena MJ, Quintero A,
Montironi R (2001). Lymphoepitheliomalike
carcinoma of the urinary bladder: a
clinicopathologic study of 13 cases.
Virchows Arch 438: 552-557.
1554. Lopez-Beltran A, Martin J, Garcia J,
Toro M (1988). Squamous and glandular
differentiation in urothelial bladder carcinomas.
Histopathology, histochemistry
and immunohistochemical expression of
carcinoembryonic antigen. Histol
Histopathol 3: 63-68.
1555. Lopez-Beltran A, Pacelli A,
Rothenberg HJ, Wollan PC, Zincke H,
Blute ML, Bostwick DG (1998). Carcinosarcoma
and sarcomatoid carcinoma of
the bladder: clinicopathological study of
41 cases. J Urol 159: 1497-1503.
1556. Lopez JI, Angulo JC (1994). Burnedout
tumour of the testis presenting as
retroperitoneal choriocarcinoma. Int Urol
Nephrol 26: 549-553.
1557. Lopez JI, Angulo JC, Ibanez T (1993).
Primary malignant melanoma mimicking
urethral caruncle. Case report. Scand J
Urol Nephrol 27: 125-126.
1558. Lopez JI, Elorriaga K, Imaz I, Bilbao
FJ (1999). Micropapillary transitional cell
carcinoma of the urinary bladder.
Histopathology 34: 561-562.
1559. Los M, Jansen GH, Kaelin WG, Lips
CJ, Blijham GH, Voest EE (1996).
Expression pattern of the von Hippel-
Lindau protein in human tissues. Lab
Invest 75: 231-238.
1560. Lothe RA, Hastie N, Heimdal K, Fossa
SD, Stenwig AE, Borresen AL (1993).
Frequent loss of 11p13 and 11p15 loci in
male germ cell tumours. Genes
Chromosomes Cancer 7: 96-101.
1561. Lothe RA, Peltomaki P, Tommerup N,
Fossa SD, Stenwig AE, Borresen AL,
Nesland JM (1995). Molecular genetic
changes in human male germ cell tumors.
Lab Invest 73: 606-614.
1562. Lott ST, Lovell M, Naylor SL, Killary
AM (1998). Physical and functional mapping
of a tumor suppressor locus for renal
cell carcinoma within chromosome 3p12.
Cancer Res 58: 3533-3537.
1563. Loughlin KR, Retik AB, Weinstein
HJ, Colodny AH, Shamberger RC, Delorey
M, Tarbell N, Cassady JR, Hendren WH
(1989). Genitourinary rhabdomyosarcoma
in children. Cancer 63: 1600-1606.
1564. Louhelainen J, Wijkstrom H,
Hemminki K (2000). Allelic losses demonstrate
monoclonality of multifocal bladder
tumors. Int J Cancer 87: 522-527.
1565. Lowe BA, Brewer J, Houghton DC,
Jacobson E, Pitre T (1992). Malignant
transformation of angiomyolipoma. J Urol
147: 1356-1358.
1566. Lowe FC, Lattimer DG, Metroka CE
(1989). Kaposi’s sarcoma of the penis in
patients with acquired immunodeficiency
syndrome. J Urol 142: 1475-1477.
1567. Lowe LH, Isuani BH, Heller RM,
Stein SM, Johnson JE, Navarro OM,
Hernanz-Schulman M (2000). Pediatric
renal masses: Wilms tumor and beyond.
Radiographics 20: 1585-1603.
1568. Lu D, Medeiros LJ, Eskenazi AE,
Abruzzo LV (2001). Primary follicular large
cell lymphoma of the testis in a child.
Arch Pathol Lab Med 125: 551-554.
1569. Lu ML, Wikman F, Orntoft TF,
Charytonowicz E, Rabbani F, Zhang Z,
Dalbagni G, Pohar KS, Yu G, Cordon-
Cardo C (2002). Impact of alterations
affecting the p53 pathway in bladder cancer
on clinical outcome, assessed by
conventional and array-based methods.
Clin Cancer Res 8: 171-179.
1570. Lubensky IA, Schmidt L, Zhuang Z,
Weirich G, Pack S, Zambrano N, Walther
MM, Choyke P, Linehan WM, Zbar B
(1999). Hereditary and sporadic papillary
renal carcinomas with c-met mutations
share a distinct morphological phenotype.
Am J Pathol 155: 517-526.
1571. Lucas DR, Lawrence WD, McDewitt
WJ (1994). Mucinous papillary adenocarcinoma
of the bladder arising within a villous
adenoma urachal remnant: an
immunohistochemical and ultrastructural
study. J Urol Pathol 2: 173-182.
1572. Lundgren L, Aldenborg F, Angervall
L, Kindblom LG (1994). Pseudomalignant
spindle cell proliferations of the urinary
bladder. Hum Pathol 25: 181-191.
1573. Lundgren R, Elfving P, Heim S,
Kristoffersson U, Mandahl N, Mitelman F
(1989). A squamous cell bladder carcinoma
with karyotypic abnormalities reminiscent
of transitional cell carcinoma. J
Urol 142: 374-376.
1574. Luo J, Duggan DJ, Chen Y,
Sauvageot J, Ewing CM, Bittner ML,
Trent JM, Isaacs WB (2001). Human
prostate cancer and benign prostatic
hyperplasia: molecular dissection by
gene expression profiling. Cancer Res 61:
4683-4688.
1575. Luo J, Zha S, Gage WR, Dunn TA,
Hicks JL, Bennett CJ, Ewing CM, Platz
EA, Ferdinandusse S, Wanders RJ, Trent
JM, Isaacs WB, de Marzo AM (2002).
Alpha-methylacyl-CoA racemase: a new
molecular marker for prostate cancer.
Cancer Res 62: 2220-2226.
1576. Luo JH, Yu YP, Cieply K, Lin F,
Deflavia P, Dhir R, Finkelstein S,
Michalopoulos G, Becich M (2002). Gene
expression analysis of prostate cancers.
Mol Carcinog 33: 25-35.
1577. Luo LY, Rajpert-De Meyts ER, Jung
K, Diamandis EP (2001). Expression of the
normal epithelial cell-specific 1 (NES1;
KLK10) candidate tumour suppressor
gene in normal and malignant testicular
tissue. Br J Cancer 85: 220-224.
1578. Luque Barona RJ, Gonzalez Campora
R, Vicioso-Recio L, Requena Tapias MJ,
Lopez-Beltran A (2000). [Synchronous prostatic
carcinosarcoma: report of 2 cases
and review of the literature]. Actas Urol Esp
24: 173-178.
1579. Lutzeyer W, Rubben H, Dahm H (1982).
Prognostic parameters in superficial bladder
cancer: an analysis of 315 cases. J Urol
127: 250-252.
1580. Lutzker SG, Levine AJ (1996). A functionally
inactive p53 protein in teratocarcinoma
cells is activated by either DNA damage
or cellular differentiation. Nat Med 2:
804-810.
1581. Lutzker SG, Mathew R, Taller DR
(2001). A p53 dose-response relationship for
sensitivity to DNA damage in isogenic teratocarcinoma
cells. Oncogene 20: 2982-2986.
1582. Lynch CF, Cohen MB (1995). Urinary
system. Cancer 75: 316-329.
1583. Lynch HT, Ens JA, Lynch JF (1990).
The Lynch syndrome II and urological
malignancies. J Urol 143: 24-28.
1584. Lytton B, Collins JT, Weiss RM, Schiff
MJr, McGuire EJ, LiVolsi VA (1979). Results
of biopsy after early stage prostatic cancer
treatment by implantation of 125I seeds. J
Urol 121: 306-309.
1585. Ma KF, Tse CH, Tsui MS (1990).
Neurilemmoma of kidney—a rare occurrence.
Histopathology 17: 378-380.
1586. Macedo AJr, Fichtner J, Hohenfellner
R (1997). Extramammary Paget’s disease of
the penis. Eur Urol 31: 382-384.
1587. Mackey JR, Au HJ, Hugh J, Venner P
(1998). Genitourinary small cell carcinoma:
determination of clinical and therapeutic
factors associated with survival. J Urol 159:
1624-1629.
1588. Macoska JA, Micale MA, Sakr WA,
Benson PD, Wolman SR (1993). Extensive
genetic alterations in prostate cancer
revealed by dual PCR and FISH analysis.
Genes Chromosomes Cancer 8: 88-97.
1589. Maddock IR, Moran A, Maher ER,
Teare MD, Norman A, Payne SJ,
Whitehouse R, Dodd C, Lavin M, Hartley N,
Super M, Evans DG (1996). A genetic register
for von Hippel-Lindau disease. J Med
Genet 33: 120-127.
1590. Maden C, Sherman KJ, Beckmann
AM, Hislop TG, Teh CZ, Ashley RL, Daling JR
(1993). History of circumcision, medical
conditions, and sexual activity and risk of
penile cancer. J Natl Cancer Inst 85: 19-24.
1591. Magee JA, Araki T, Patil S, Ehrig T,
True L, Humphrey PA, Catalona WJ,
Watson MA, Milbrandt J (2001). Expression
profiling reveals hepsin overexpression in
prostate cancer. Cancer Res 61: 5692-5696.
1592. Magi-Galluzi C, Xu X, Hlatky L,
Hahnfeldt P, Kaplan I, Hsiao P, Chang C,
Loda M (1997). Heterogeneity of androgen
receptor content in advanced prostate cancer.
Mod Pathol 10: 839-845.
1593. Magi-Galluzzi C, Luo J, Isaacs WB,
Hicks JL, de Marzo AM, Epstein JI (2003).
Alpha-methylacyl-CoA racemase: a variably
sensitive immunohistochemical marker
for the diagnosis of small prostate cancer
foci on needle biopsy. Am J Surg Pathol
27: 1128-1133.
1594. Magri J (1960). Cysts of the prostate
gland. Br J Urol 32: 295-301.
1595. Magro G, Cavallaro V, Torrisi A, Lopes
M, Dell’Albani M, Lanzafame S (2002).
Intrarenal solitary fibrous tumor of the kidney
report of a case with emphasis on the
differential diagnosis in the wide spectrum
of monomorphous spindle cell tumors of the
kidney. Pathol Res Pract 198: 37-43.
1596. Mahadevia PS, Koss LG, Tar IJ
(1986). Prostatic involvement in bladder
cancer. Prostate mapping in 20 cystoprostatectomy
specimens. Cancer 58:
2096-2102.
1597. Maher ER, Kaelin WGJr (1997). von
Hippel-Lindau disease. Medicine
(Baltimore) 76: 381-391.
1598. Maher ER, Yates JR, Ferguson-Smith
MA (1990). Statistical analysis of the two
stage mutation model in von Hippel-Lindau
disease, and in sporadic cerebellar haemangioblastoma
and renal cell carcinoma.
J Med Genet 27: 311-314.
1599. Maher JD, Thompson GM, Loening
S, Platz CE (1988). Penile plexiform neurofibroma:
case report and review of the literature.
J Urol 139: 1310-1312.
1600. Maheshkumar P, Harper C,
Sunderland GT, Conn IG (2000). Cystic
epithelial stromal tumour of the seminal
vesicle. BJU Int 85: 1154.
1601. Mahmoudi T, Verrijzer CP (2001).
Chromatin silencing and activation by
Polycomb and trithorax group proteins.
Oncogene 20: 3055-3066.
1602. Mahoney JP, Saffos RO (1981). Fetal
rhabdomyomatous nephroblastoma with a
renal pelvic mass simulating sarcoma
botryoides. Am J Surg Pathol 5: 297-306.
1603. Mahran MR, el Baz M (1993).
Verrucous carcinoma of the bilharzial
bladder. Impact of invasiveness on survival.
Scand J Urol Nephrol 27: 189-192.
1604. Mai KT (1994). Giant renomedullary
interstitial cell tumor. J Urol 151: 986-988.
1605. Mai KT, Isotalo PA, Green J, Perkins
DG, Morash C, Collins JP (2000). Incidental
prostatic adenocarcinomas and putative
premalignant lesions in TURP specimens
collected before and after the introduction
of prostrate-specific antigen screening.
Arch Pathol Lab Med 124: 1454-1456.
1606. Mai KT, Perkins DG, Collins JP
(1996). Epithelioid cell variant of renal
angiomyolipoma. Histopathology 28: 277-
280.
1607. Maiche AG (1992). Epidemiological
aspects of cancer of the penis in Finland.
Eur J Cancer Prev 1: 153-158.
1608. Maiche AG, Pyrhonen S, Karkinen M
(1991). Histological grading of squamous
cell carcinoma of the penis: a new scoring
system. Br J Urol 67: 522-526.
1609. Maiti S, Chatterjee G, Pal SN,
Mukherjee DR (1990). Benign cystic teratoma
of the testis. J Indian Med Assoc
88: 287-288.
1610. Malmstrom PU, Busch C, Norlen BJ
(1987). Recurrence, progression and survival
in bladder cancer. A retrospective
analysis of 232 patients with greater than
or equal to 5-year follow-up. Scand J Urol
Nephrol 21: 185-195.
1611. Maluf HM, King ME, de Luca FR,
Navarro J, Talerman A, Young RH (1991).
Giant multilocular prostatic cystadenoma:
a distinctive lesion of the retroperitoneum
in men. A report of two cases. Am J Surg
Pathol 15: 131-135.
1612. Mancilla-Jimenez R, Stanley RJ,
Blath RA (1976). Papillary renal cell carcinoma:
a clinical, radiologic, and pathologic
study of 34 cases. Cancer 38: 2469-2480.
1613. Manglani KS, Manaligod JR, Ray B
(1980). Spindle cell carcinoma of the glans
penis: a light and electron microscopic
study. Cancer 46: 2266-2272.
1614. Manivel JC, Fraley EE (1988).
Malignant melanoma of the penis and
male urethra: 4 case reports and literature
review. J Urol 139: 813-816.
330 References